Back

Real-world effectiveness of stroke prevention in patients with non-valvular atrial fibrillation treated with rivaroxaban vs. phenprocoumon in germany - insights from the reload study

28 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Stroke prevention Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Hendrik Bonnemeier

Schleswig-Holstein University Clinic, Lubeck Campus, Luebeck (Germany)

53 More presentations in this session

Presentation thumbnail
Doctor A. Tyminska (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Doctor M. Gupta (Toronto, CA)
Abstract
Presentation thumbnail
Ms D. Loikas (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Doctor J. Franchino-Elder (Ridgefield, US)
Abstract
Presentation thumbnail
Doctor F. Melillo (Milan, IT)
Abstract

Access the full session

Session thumbnail
Poster session 4 - Stroke prevention

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources